Open AccessAdjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow-up
Author(s) -
Luigi Gallo,
Stefano Pecoraro,
Pasquale Sarnacchiaro
Publication year - 2022
Publication title -
investigative and clinical urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.653
H-Index - 14
eISSN - 2466-054X
pISSN - 2466-0493
DOI - 10.4111/icu.20210317
Subject(s) - medicine , tadalafil , erectile dysfunction , extracorporeal shockwave therapy , extracorporeal shock wave therapy , urology , prospective cohort study , extracorporeal , randomized controlled trial , surgery